{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T06:36:22Z","timestamp":1793255782448,"version":"4.5.0"},"reference-count":90,"publisher":"SAGE Publications","issue":"10","license":[{"start":{"date-parts":[[2015,8,10]],"date-time":"2015-08-10T00:00:00Z","timestamp":1439164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Psychopharmacol"],"published-print":{"date-parts":[[2015,10]]},"abstract":"<jats:p>The aim of this review is to summarise the literature on the efficacy and safety of pregabalin for the treatment of generalised anxiety disorder (GAD). Of 241 literature citations, 13 clinical trials were identified that were specifically designed to evaluate the efficacy and safety of pregabalin in GAD, including 11 randomised double-blind trials and two open-label studies. Pregabalin efficacy has been consistently demonstrated across the licensed dose range of 150\u2013600 mg\/day. Efficacy has been reported for pregabalin monotherapy in elderly patients with GAD, patients with severe anxiety, and for adjunctive therapy when added to a selective serotonin reuptake inhibitor or serotonin-norepinephrine reuptake inhibitor in patients who have failed to respond to an initial course of antidepressant therapy. The two most common adverse events with pregabalin are somnolence and dizziness, both of which appear to be dose-related. Pregabalin appears to have a low potential for causing withdrawal symptoms when long-term therapy is discontinued; however, tapering over the course of at least one week is recommended. A review of available evidence indicates that pregabalin is a well-tolerated and consistently effective treatment for GAD, with a unique mechanism of action that makes it a useful addition to the therapeutic armamentarium.<\/jats:p>","DOI":"10.1177\/0269881115598411","type":"journal-article","created":{"date-parts":[[2015,8,10]],"date-time":"2015-08-10T21:19:48Z","timestamp":1439241588000},"page":"1047-1060","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":55,"title":["Efficacy and safety of pregabalin in generalised anxiety disorder: A critical review of the literature"],"prefix":"10.1177","volume":"29","author":[{"given":"David S","family":"Baldwin","sequence":"first","affiliation":[{"name":"Clinical and Experimental Sciences, University of Southampton, Southampton, UK"},{"name":"Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan A","family":"den Boer","sequence":"additional","affiliation":[{"name":"PRA Health Sciences, AE Zuidlaren, the Netherlands"},{"name":"Department of Nuclear Medicine and Molecular Imaging, University of Groningen, Groningen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin","family":"Lyndon","sequence":"additional","affiliation":[{"name":"Pfizer Ltd, Tadworth, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birol","family":"Emir","sequence":"additional","affiliation":[{"name":"Pfizer Inc., New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Schweizer","sequence":"additional","affiliation":[{"name":"Paladin Consulting Group, Princeton, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Haswell","sequence":"additional","affiliation":[{"name":"Pfizer Ltd, Tadworth, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2015,8,10]]},"reference":[{"key":"bibr1-0269881115598411","first-page":"28","volume":"420","author":"Alonso J","year":"2004","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"bibr2-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596"},{"key":"bibr3-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1177\/0269881113503509"},{"key":"bibr4-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1177\/0269881114525674"},{"key":"bibr5-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2011.07.005"},{"key":"bibr6-0269881115598411","doi-asserted-by":"publisher","DOI":"10.3109\/13651501.2012.667114"},{"key":"bibr7-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1586\/14737175.7.7.769"},{"key":"bibr8-0269881115598411","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200418010-00004"},{"key":"bibr9-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-984400"},{"key":"bibr10-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1177\/070674371105600907"},{"key":"bibr11-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1291176"},{"key":"bibr12-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.2006.04913.x"},{"key":"bibr13-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2005.19204.x"},{"key":"bibr14-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.162.6.1179"},{"key":"bibr15-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2012.684044"},{"key":"bibr16-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2007.01.944"},{"key":"bibr17-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2008.01194.x"},{"key":"bibr18-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.148.11.1512"},{"key":"bibr19-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1007\/BF02246094"},{"key":"bibr20-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291799008351"},{"key":"bibr21-0269881115598411","first-page":"S40","volume":"51","author":"Fawcett J","year":"1990","journal-title":"J Clin Psychiatry"},{"key":"bibr22-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e3282f0f0d7"},{"key":"bibr23-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000084032.22282.ff"},{"key":"bibr24-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.106.022384"},{"key":"bibr25-0269881115598411","first-page":"S194","volume":"7","author":"Fieve RR","year":"2004","journal-title":"Int J Neuropsychopharmacol"},{"key":"bibr26-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.151.5.640"},{"key":"bibr27-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1007\/s10928-009-9137-5"},{"key":"bibr28-0269881115598411","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200620080-00010"},{"key":"bibr29-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.113.126003"},{"key":"bibr30-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1177\/0269881111405360"},{"key":"bibr31-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1037\/0022-006X.75.6.939"},{"key":"bibr32-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2004.07.006"},{"key":"bibr33-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1177\/0269881107076996"},{"key":"bibr34-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/28.2.187"},{"key":"bibr35-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-005-0172-7"},{"key":"bibr36-0269881115598411","first-page":"293","volume":"49","author":"Hoehn-Saric R","year":"1988","journal-title":"J Clin Psychiatry"},{"key":"bibr37-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145712000922"},{"key":"bibr38-0269881115598411","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.3109\/13651501.2010.525357","volume":"14","author":"Kasper S","year":"2010","journal-title":"Int J Psychiatry Clin Pract"},{"key":"bibr39-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e32831d7980"},{"key":"bibr40-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145713001557"},{"key":"bibr41-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291706009135"},{"key":"bibr42-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.publhealth.29.020907.090847"},{"key":"bibr43-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.62.6.593"},{"key":"bibr44-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.156.12.1915"},{"key":"bibr45-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.12.4.663"},{"key":"bibr46-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychores.2007.03.004"},{"key":"bibr47-0269881115598411","volume-title":"Abstract for the annual meeting of the American Society of Clinical Pharmacology and Therapeutics (ASCPT)","author":"Lockwood P","year":"2014"},{"key":"bibr48-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145709990460"},{"key":"bibr49-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.3.5.485"},{"key":"bibr50-0269881115598411","first-page":"45","volume-title":"Diagnostic Issues in Depression and Generalized Anxiety Disorder: Refining the Research Agenda for DSM-5","author":"Martin EL","year":"2010"},{"key":"bibr51-0269881115598411","doi-asserted-by":"publisher","DOI":"10.2165\/11634510-000000000-00000"},{"key":"bibr52-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000155821.74832.f9"},{"key":"bibr53-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291706009640"},{"key":"bibr54-0269881115598411","first-page":"211","volume":"16","author":"Moller H-J","year":"2009","journal-title":"Psychopharmakotherapie"},{"key":"bibr55-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.107.037788"},{"key":"bibr56-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2013.820694"},{"key":"bibr57-0269881115598411","unstructured":"Montgomery S, Prieto R, Emir B, (2012) Long-term study of pregabalin for the treatment of generalized anxiety disorder: A 1-year open-label extension. 20th European Congress of Psychiatry. Prague, Czech Republic, 3\u20136 March 2012. Available at: http:\/\/www.epa-congress.org\/useful-links\/previous-congresses#.VbIXXaNwaUk (accessed 24 July 2015)."},{"key":"bibr58-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.7.15.2139"},{"key":"bibr59-0269881115598411","doi-asserted-by":"publisher","DOI":"10.4137\/CMT.S1103"},{"key":"bibr60-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e32832dceb9"},{"key":"bibr61-0269881115598411","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v67n0511"},{"key":"bibr62-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1994.03520220035028"},{"key":"bibr63-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1358\/dot.2007.43.9.1133188"},{"key":"bibr64-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.3.533"},{"key":"bibr65-0269881115598411","unstructured":"Pfizer Inc. (2013) LYRICA\u00ae EU product information. Available at: http:\/\/www.emea.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000546\/WC500046602.pdf (first published 23 September 2009, last updated 6 March 2013, accessed 3 April 2013)."},{"key":"bibr66-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000155820.74832.b0"},{"key":"bibr67-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1177\/0091270003251119"},{"key":"bibr68-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.4.637"},{"key":"bibr69-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1586\/ern.12.32"},{"key":"bibr70-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1993.01820230054005"},{"key":"bibr71-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.62.9.1022"},{"key":"bibr72-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e328350b133"},{"key":"bibr73-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1159\/000324850"},{"key":"bibr74-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852900022367"},{"key":"bibr75-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e328341bb4a"},{"key":"bibr76-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1002\/gps.1001"},{"key":"bibr77-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1998.tb05973.x"},{"key":"bibr78-0269881115598411","first-page":"82","volume":"11","author":"Shear KM","year":"2012","journal-title":"World Psychiatry"},{"key":"bibr79-0269881115598411","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v62n07a04"},{"key":"bibr80-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1080\/15563650801986497"},{"key":"bibr81-0269881115598411","unstructured":"Stein DJ, Mandel FS, Szczypa P (2009) Tension in generalized anxiety disorder: A relatively neglected treatment target. 162nd Annual Meeting of the American Psychiatric Association. San Francisco, CA, 16\u201321 May 2009. Available at: http:\/\/www.psychiatry.org\/File%20Library\/Learn\/Archives\/am_syllabus_2009.pdf (accessed 24 July 2015)."},{"key":"bibr82-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1177\/2042098613505614"},{"key":"bibr83-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1159\/000139363"},{"key":"bibr84-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1Q405"},{"key":"bibr85-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2005.04.012"},{"key":"bibr86-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2011.07.018"},{"key":"bibr87-0269881115598411","first-page":"S24","volume":"63","author":"Wittchen HU","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"bibr88-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1007\/s13181-010-0052-3"},{"key":"bibr89-0269881115598411","volume-title":"The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines","author":"World Health Organization","year":"1992"},{"key":"bibr90-0269881115598411","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-012-1213-x"}],"container-title":["Journal of Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0269881115598411","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/0269881115598411","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0269881115598411","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:08:19Z","timestamp":1777507699000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0269881115598411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,10]]},"references-count":90,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["10.1177\/0269881115598411"],"URL":"https:\/\/doi.org\/10.1177\/0269881115598411","relation":{},"ISSN":["0269-8811","1461-7285"],"issn-type":[{"value":"0269-8811","type":"print"},{"value":"1461-7285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,10]]}}}